Skip to main content
Premium Trial:

Request an Annual Quote

Pangenome Analysis Strategy Provides Look at Conserved, Variable Genome Regions

Stanford University researchers reporting in Cell Reports Methods describe a strategy for comparing a human pangenome reference sequence with individual reference genomes. With this indexing approach, the team tracked down a set of universally conserved sequences dubbed "pan-conserved segment tags" (PSTs) found in the HPRC pangenome assembly, the GRCh38 human genome reference, and a haploid genome assembly from the Telomere-to-Telomere Consortium. These ultra-conserved PSTs were separated by one another by stretches of conserved or variable sequences, the authors note, providing insights into informative polymorphic intervals between PSTs, including sequences within the pangenome that varied by population or ethnicity. "Determining the conserved gene features among individual with different genetic backgrounds provides many important features of the pangenome," they write. "By examining conserved sequences, certain properties of [structural variation] become apparent including what regions of the genome are most subject to polymorphic rearrangements."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.